Glucagon-like peptide-1 (GLP-1) and Gastric inhibitory polypeptide (GIP) while Ozempic (Semaglutide) only targets GLP-1.
Weight loss drugs have surged in popularity. But Gov. Ned Lamont wants CT’s Medicaid program to discontinue covering them for ...
Mann Ki Baat’ radio broadcast, Prime Minister Narendra Modi highlighted the growing obesity epidemic in India, referencing ...